VIDEO: Providers should include drospirenone in their arsenal of OC options
June 11, 2014|Pediatric News
Author and Disclosure Information
EXPERT ANALYSIS FROM NASPAG ANNUAL MEETING
PHILADELPHIA – Despite recent controversy over the risk of venous thromboembolism in users of combination contraceptive pills containing drospirenone, Dr. Jennifer Dietrich, associate professor of obstetrics and gynecology at Baylor College of Medicine, Houston, urges providers to carefully weigh the associated risks and benefits against the threat of an unwanted pregnancy when prescribing to adolescents.
"Counsel your patient carefully, and help them choose the right method," Dr. Dietrich said at the annual meeting of the North American Society for Pediatric and Adolescent Gynecology. "Even when it includes drospirenone."
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
On Twitter @whitneymcknight